Patients with von Willebrand disease (VWD) frequently bleed under a challenge.The aim of our study was to identify predictive markers of perioperative major haemorrhage in type 1 (VWF:RCo = 15-30 IU dl-1) and possible type 1 (VWF:RCo = 31-49 IU dl-1)VWD patients.We recorded perioperative bleeding complications previous to diagnosis and laboratory parameters in 311 patients with 498 surgical procedures.The patients were grouped according to the absence (A) or presence (B) of perioperative major haemorrhages. Eighty-one patients (26%) and 87 surgical procedures (17.5%) presented major haemorrhages associated with surgeries.There was no difference between the percentage of type 1 and possible type 1 VWD patients who had major haemorrhages (32.6% and 24.8% respectively; p=ns). No difference in the prevalence of O blood group, age, gender, positive family history and laboratory test results (FVIII and VWF) was observed, independent of the haemorrhagic tendency. Bleeding after tooth extraction was the most frequent clinical feature observed in patients with perioperative major haemorrhages. The bleeding score and the number of bleeding sites (≥3) were not predictors of major haemorrhage associated with surgery. Caesarean section and adenotonsillectomy showed the highest frequency of major haemorrhages (24.6% and 22.3%, respectively). In conclusion, type 1 and possible type 1VWD patients showed similar incidence of perioperative major haemorrhages. Laboratory tests and positive family history did not prove to be effective at predicting major haemorrhages in patients that had either type 1 or possible type 1 VWD.The history of bleeding after tooth extraction could define risk factors of major haemorrhage.
Introduction
Clinical manifestations of the von Willebrand disease (VWD) include mucocutaneous bleeding, postpartum haemorrhage, and post surgical haemorrhage (1) . VWD are rarely associated with spontaneous bleeding but may result in a possibly severe haemorrhage after a haemostatic challenge such as trauma or surgery (2) . Nevertheless, incomplete VWD penetrance and low specificity of the bleeding symptoms make type 1 VWD a clinical and biologic diagnostic challenge (3). Sadler (4) suggested that the term "type 1 VWD" is reasonable for patients with exceptionally low VWF levels (near 15 IU dl -1 ), frequent bleeding, and dominant inheritance. Also is accepted by others, for VWF deficiency, usually in the range of 10-30 U dl -1 (5, 6) , whereas the majority of subjects with low VWF (30-50 IU dl -1 ) and mild bleeding symptoms may be considered as "low VWF" or "possible" type 1 VWD (3, 6, 7) . The ISTH VWF Subcomitee (8) updated the previous classification without a restrictive criterion related to mutations. Woods et al (1) considered that low levels of VWF:RCo and personal bleeding history are crucial in the diagnosis and treatment of VWD. Despite the fact that VWF values below 40 IU dl -1 appeared to increase the likelihood of having type 1 VWD, a cut-off of 30 IU dl -1 has been recommended for the diagnosis of VWD (9) .
Although these patients usually do not require treatment (3), very often, an improper management can lead to severe haemorrhage complications during or after surgery (10, 11) . Allen et al. (12) suggested that although adenotonsillectomy can be performed safely in patients with VWD, it is not without an increased risk of perioperative bleeding. Nitu-Whalley (13) reported that patients with VWD not carry an increased operative risk if appropriate therapy is given. The treatment of patients with VWD undergoing surgery is a challenging task, mainly when the haemostatic response cannot be accurately predicted (13) . There are very few studies about the incidence of haemorrhages during surgery. In this work, a retrospective cohort of patients with type 1 and possible type 1 VWD, with major haemorrhages related to surgeries occurring before VWD diagnosis, was analyzed.
Materials and methods

Study Design
The design was a single-center retrospective study, in which analysis of data of 2300 clinical histories belonging to patients with type 1 and possible type 1 VWD, diagnosed, and regularly followed up at our Institute. The Medical Ethics Committee of the Institution approved this study and informed consent was obtained from patients during their first interview. A total of 311 patients undergoing 498 surgical procedures before diagnosis were identified. The data concerning the absence (group A) or presence (group B) of major hemorrhages related to surgery, was recorded in each surgical event.
Group A: Patients without major hemorrhages related to surgery. Two hundred thirty patients (33 type 1 VWD and 197 possible type 1 VWD) with a median of 33 years old (range 2-64). These patients underwent 348 surgical events, including 128 major surgeries, 89 minor surgeries, 85 adenotonsillectomies, and 46 caesarean sections.
Group B: Patients with major hemorrhages related to surgery. Eighty-one patients (16 type 1 VWD and 65 possible type 1 VWD) with at least one perioperative major haemorrhage and a median of 33 years old (range 6-66). These patients underwent 150 surgical events including 38 major surgeries, 48 minor surgeries, 45 adenotonsillectomies, and 19 caesarean sections. 
Data acquisition
Information about age at the time of diagnosis, type of ABO blood group, and coagulation's laboratory tests was collected and analyzed using the SPSS software for Windows. Most of patients had a minimum of three laboratory results; as commonly occurred in clinical practice, the most abnormal value for any given test was considered for the analysis (14) .
The personal and family bleeding histories were obtained from a detailed questionnaire by the staff haematologist to the interviewing patients (or parents in case of children). Symptoms investigated included: epistaxis, menorrhagia, ecchymoses, bleeding after tooth extraction, postpartum, surgery, and caesarean section, haematomas, haemarthrosis, and haematuria.
Major haemorrhage was defined as cerebral, retroperitoneal, pericardial, peritoneal or intraocular bleeding, as bleeding requiring hospitalization, surgery or blood transfusion ≥2 units or as bleeding causing a hemoglobin drop ≥2 g dl -1 (15, 16) . Menorrhagia was defined in those cases when the pictorial chart was ≥185 according to the Pictorial Bleeding Assesment Chart Scoring method as described before (17) . Epistaxis was defined as bleeding that the subject or parents recognized as significant, without a history of trauma not stopped by short compression of <10 min, or requiring blood transfusion. The presence of haematomas, oral or gum bleeding, gastrointestinal or rectal bleeding, and haematuria resulting from minimal trauma or occurring spontaneously as a presenting symptom or requiring medical treatment, was recorded (14) . A positive family history requires that at least one first-degree relative, or at least two seconddegree relatives, have a personal history of significant mucocutaneous bleeding.
Bleeding score and number of bleeding sites calculation
For each patient, the severity of each symptom was subsequently summarized, using the bleeding score system (BS) ranging from 0 to 3, according to the ISTH recommendations (18, 19) , and considering for each symptom the most severe occurrence (20) . The BS and number of bleeding sites were calculated in two ways: firstly, including the major haemorrhage episodes related to surgery, given that they actually are the real patient's clinical pattern at the moment of their consultation at the Centre; secondly, excluding the episode of major haemorrhage related to surgery to establish if they could be predictors of surgical bleeding. BS ≥5 in females and ≥3 in males were considered sensitive for bleeding history (20) .
Types of surgery
Surgical procedures were divided into 4 main groups: adenotonsillectomy, obstetric delivery by caesarean section, major surgeries (abdominal, ophthalmic, cardiac, neurological, orthopaedic, hip replacement, breast, prostate, lung, renal), and minor surgeries (biopsies, uterine surgeries, invasive procedures, such as arthroscopy, episiotomy, endoscopy, cystoscopy, skin excision) (13) .
Laboratory tests
The following laboratory data were collected from the clinical histories: FVIII, VWF:Ag, and VWF:RCo values. FVIII was assayed by the one-stage method (21) (normal range 50-150 IU dl . VWF values were not adjusted for blood group.
Standard plasma
The standard was "in-house" normal plasma pool from at least 20 healthy donors. APTT and FVIII were checked in each donor. Relative risk (RR) and its 95% confidence interval were also calculated, to evaluate the degree of association between BS, the number of bleeding sites, and the clinical symptoms.
As the bleeding score is a summative index of ordinal values not normally distributed, we used median values and the Mann-Whitney rank sum test to assess differences in BS between subgroups of enrolled subjects. A multivariate analysis was performed to determine whether positive family history, BS, three or more bleeding sites, clinical symptoms, and laboratory parameters were independently related to haemorrhagic risk in surgeries.
Results
Enrolled patients, surgical events and laboratory data
The base-line characteristics of the 311 sujects are given in Table 1 . The population was grouped according to the absence (group A=230 patients) or presence (group B=81 patients) of major haemorrhages related to surgery. There were not significant differences in gender, O blood group, or age between groups A and B.
BS and the number of bleeding sites were calculated at entry, including the surgical sentinel event. As shown in Table 1 , the differences between groups B and A, reached statistic significance.
A total of 498 surgical events were registered: 130 adenotonsillectomies, 65 caesarean sections, 166 major surgeries, and 137 minor surgeries. Eigthty-seven surgeries (17.5%) displayed major haemorrhages, as follows: 16 out of 65 (24.6%) caesarean sections, 29 out of 130 (22.3%) adenotonsillectomies, 21 out of 166 (12.6%) major surgeries, and 21 out of 137 (15.3%) minor surgeries.
Twenty-six per cent (81/311) of the patients had suffered major haemorrhages. A 32.6% (16/49) of type 1 VWD patients showed major haemorrhages, as well as 24.8% (65/262) of possible type 1 VWD patients. The difference between both groups was not statistically significant. Table 2 shows laboratory tests in group A and B. There were not significant differences in mean values of FVIII, VWF:Ag or VWF:RCo between groups A and B neither in type 1 nor in possible type 1 patients.
Bleeding symptoms and bleeding score
We tested whether the BS or any bleeding symptom could be useful to anticipate bleeding after surgery. Therefore, BS and the number of bleeding sites were calculated excluding the surgical event, (see table 3 ). No significant differences were observed in group A and in group B, among possible type 1 and type 1. As shown in table 4, a higher frequency of patients with bleeding after tooth extraction (P<0.0000; RR= 2.02; 95% CI=1.3-3.1) was observed in group B. This difference reached statiscal significance in the possible type 1 patients (RR=2.11; 95% CI=1.3-3.5), but not in type 1. There was no significant difference in the frequency of the other bleeding symptoms in group A and in group B, among possible type 1 and type 1.
Multivariate analysis showed that none of those studied variables was an independent determinant of haemorrhagic risk related to surgery.
Discussion
Mild forms of VWD may have increased bleeding during surgical procedures (11, 24) . Identifying these patients before surgery is a key consideration. There are few studies establishing biological predictive markers of bleeding related to surgery in VWD (10, 25) . We attempt to address this issue by considering the diagnosis of those mild forms. Ziv et al (14) reported that the postoperative bleeding could have been avoided in 83% of cases if a preoperative bleeding history or family history had been obtained. We think that a personal positive bleeding history would be able to prevent postoperative major haemorrhage, but our results do not support that a family history may predict the future presence of major haemorrhage in the surgeries. Therefore, the inclusion of family history appears to be of little relevance and some authors avoid it (26).
It has been described (20) that menorrhagia and epistaxis were poor predictors of the disease, while mucocutaneous bleeding and bleeding after tooth extractions were more sensitive symptoms for diagnosis. In our case, menorrhagia, epistaxis, haematomas, and postpartum haemorrhage were also poor predictors of major haemorrhage associated with surgery, in both type 1 and possible type 1 VWD patients. Bleeding after tooth extraction was the only clinical symptom that appears to be strongly associated with major haemorrhage related to surgery, and therefore the only predictor.
Tosetto et al (2) suggested that the BS at the time of the diagnosis may be useful in the evaluation of the bleeding patients for both the researcher and medical practitioner although at present, it is not possible to give a clear answer. Higher BS was related with increasing likelihood of VWD, and strongly associated with bleeding after surgery or tooth extraction (24) . Values of BS ≥5 for females and ≥3 for males, have been reported as very specific in order to identify haemorrhagic tendency of type 1 patients (20) . In several reports (24, 26, 27) about BS, their value was always significant when it was calculated considering the bleeding in surgeries. When the BS was calculated excluding the surgical event, it was not predictor of major haemorrhage associated with surgery in spite of their occurrence.
We have previously described that three or more bleeding sites were frequent in patients with VWD (1). Our results showed that the number of bleeding sites was slight higher in females, independently the presence or not of major haemorrhage related to surgery, when this event was excluded from the evaluation. In contrast, when surgical event was included, a strong association between the number of bleeding sites (≥3) with major haemorrhage related to surgery was observed. In agreement with Quiroga et al, who have reported (28) that the clinical classification and BS, as indices of bleeding severity, were not significantly correlated with FVIII, VWF:Ag or VWF:RCo values, our results showed that neither FVIII nor VWF levels were markers of major haemorraghic risk. However, it has been described (29) that in type 1 VWD, FVIII level is the best predictor of haemorrhage risk at delivery, and the main determinant of postoperative bleeding and postpartum haemorrhage (30) . The discrepancy between our results and those of Conti (29) and Mannucci (30) might be attributable to the different population analysed. We have selected patients having or not major haemorrhage related to surgery between a range of 15-49 IU dl -1 VWF RCo. With regard to VWF:Ag levels, Biron et al (3) described a cohort of 832 patients who underwent surgery, 30 of whom had VWF:Ag values below lower limits, but none of them had either excessive haemorrhage after surgery or postoperative complications. In addition, no differences in bleeding tendency were observed between patients with low and normal VWF:Ag levels. We agree with the fact that VWF:Ag is rarely useful in emergency situations, especially before surgery. It is important to stress that in the present analysis, the percentages of type 1 and possible type 1 VWD patients with major haemorrhage associated to surgery were similar (32.6% and 24.8% respectively). This observation suggests that there must be other factors involved in the bleeding risk, in addition to FVIII and VWF levels. The highest frequency of major haemorrhagic complications was associated to caesarean sections and adenotonsillectomies (24.6% and 22.3%, respectively), whereas in major and minor surgeries the frecuency of major haemorrhage was 12.6% and 15.3% respectively. These results are in agreement with those reported by Silwer (31) .
In conclusion, previous personal bleeding history, especially bleeding after tooth extraction, and the type of the surgery appear to be predictive markers of major haemorrhage related to surgery in patients with type 1 and possible type 1 VWD. The failure to prevent major haemorrhage complications is a serious and substantial problem in global health care, but specifically in developing countries. Group A: patients without haemorrhage related to surgery. Group B: patients with major haemorrhages related to surgery. ‡: P possible type 1 group B vs possible type 1 group A=0.027. *: P total group B vs total group A<0.0000 Group A: patients without haemorrhage related to surgery. Group B: patients with major haemorrhages related to surgery. *: P possible type 1 group B vs possible type 1 group A<0.000 ‡: P total group B vs total group A<0.0000
